- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Hong Kong Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Results
8
This screener pinpoints dividend all-stars that boast strong fundamentals with yields typically exceeding 3%.
8 companies
Tong Ren Tang Technologies
Market Cap: HK$6.1b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.72
7D
-4.1%
1Y
-9.8%
Consun Pharmaceutical Group
Market Cap: HK$12.4b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$14.28
7D
-5.1%
1Y
68.4%
Shandong Xinhua Pharmaceutical
Market Cap: HK$10.5b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$6.97
7D
-3.9%
1Y
16.4%
Essex Bio-Technology
Market Cap: HK$2.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.47
7D
-0.9%
1Y
69.3%
Shanghai Haohai Biological Technology
Market Cap: HK$11.6b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$27.20
7D
-3.1%
1Y
-5.2%
China Shineway Pharmaceutical Group
Market Cap: HK$6.7b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.65
7D
-5.9%
1Y
4.5%
Jacobson Pharma
Market Cap: HK$3.0b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.39
7D
-3.5%
1Y
75.9%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.7b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.16
7D
-1.7%
1Y
-5.7%